Codexis to Participate in TD Cowen 44th Annual Health Care Conference
February 26 2024 - 8:05AM
Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company,
today announced the Company will attend the TD Cowen 44th Annual
Health Care Conference, being held March 4-6, 2024, in Boston,
Massachusetts.
Management will participate in a fireside chat
on Monday, March 4, 2024, at 2:50 pm ET. A live webcast of the
event will be available here and in the Investor Relations section
of the Company’s website, http://ir.codexis.com. A replay will
be archived for 90 days following the event.
About Codexis
Codexis is a leading enzyme engineering company
leveraging its proprietary CodeEvolver® technology platform to
discover, develop and enhance novel, high-performance enzymes and
other classes of proteins. Codexis enzymes solve for real-world
challenges associated with small molecule pharmaceuticals
manufacturing and nucleic acid synthesis. The Company is currently
developing its proprietary ECO Synthesis™ manufacturing platform to
enable the scaled manufacture of RNAi therapeutics through an
enzymatic route. Codexis’ unique enzymes can drive improvements
such as higher yields, reduced energy usage and waste generation,
improved efficiency in manufacturing and greater sensitivity in
genomic and diagnostic applications. For more information,
visit https://www.codexis.com.
For More Information
Investor ContactCarrie McKim(336) 608-9706ir@codexis.com
Media ContactLauren Musto(650) 421-8205media@codexis.com
Codexis (NASDAQ:CDXS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Codexis (NASDAQ:CDXS)
Historical Stock Chart
From Jul 2023 to Jul 2024